On behalf of Northland Investment (33 Locke Drive L.P.), R.W. Holmes has sold 33 Locke Dr. to Janelon Trust for $7.15 million. 33 Locke Dr. is a two story 60,477 s/f first class office and laboratory building 95% leased to Sepracor.
Sepracor is a leading research based pharmaceutical company that develops, manufactures, and sells drugs for respiratory and central nervous system disorders.
Garry Holmes, SIOR represented Northland along with Bruce Lusa and Bruce Nolen Northland's acquisition/Disposition director and vice president of Asset Management respectively.
Bill Sullivan vice president of R.W. Holmes represented Janelon Trust. WRT Management will be responsible for the day to day operations of the property.